Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
04/2002
04/04/2002WO2002026258A2 Treatment of immune-mediated diseases by oral administration of plasma fractions
04/04/2002WO2002026256A1 Excessive antibody production inhibitors, process for producing the same and method of using the same
04/04/2002WO2002026217A2 Composition for the transdermal delivery of fentanyl
04/04/2002WO2002026214A1 Ion-strength independent sustained release pharmaceutical formulation
04/04/2002WO2002014281A8 Pyridine derivatives as inhibitors of p38
04/04/2002WO2002000662B1 Improvements in and relating to chromophores
04/04/2002WO2002000167A3 Modified forms of pharmacologically active agents and uses therefor
04/04/2002WO2001097837A8 Solubilised protein vaccines
04/04/2002WO2001097795A3 Systems and methods for treating a mucosal surface
04/04/2002WO2001094347A8 Tetracyclic diketopiperazine compounds as pdev inhibitors
04/04/2002WO2001089451A3 Protease inhibitors
04/04/2002WO2001087376A8 Drug/drug delivery systems for the prevention and treatment of vascular disease
04/04/2002WO2001087263A3 Delivery systems for treatment of vascular disease
04/04/2002WO2001081332A3 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
04/04/2002WO2001073034A3 Beta-like glycoprotein hormone polypeptide and heterodimer
04/04/2002WO2001073033A3 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
04/04/2002WO2001070678A3 Substituted biphenyl derivatives
04/04/2002WO2001066098A3 Therapeutic uses of ppar mediators
04/04/2002WO2001064896A3 Human enzyme molecules
04/04/2002WO2001053353A3 Recombinant antibodies to human interkleukin-1 beta
04/04/2002WO2001048231A3 Method of achieving persistent transgene expression
04/04/2002WO2001034182A3 Composition for treating respiratory tract infections containing menthol, eucalyptol and an alpha-amylase
04/04/2002US20020040148 Diphenyl heterocyclic thioamide derivatives
04/04/2002US20020040060 2'-methyl-biphenyl-2-carboxylic acid-(3,5-bis-trifluoromethyl-benzyl)-methyl-amide, for example; treating disease related to neurokinin 1 receptor
04/04/2002US20020040040 N-(3,5-bis-trifluoromethyl-benzyl)-6-(4-hydroxyacetyl-piperazin-1 -yl)-N-methyl-4-o-tolyl-nicotinamide, for example
04/04/2002US20020040039 Treatment of inflammation with a combination of a cyclooxygenase-2 inhibitor and an integrin alpha-v antagonist
04/04/2002US20020040025 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
04/04/2002US20020040022 Administering a therapeutically effective amount of a heterocyclic compound to the patient for the treatment of inosine monophosphate dehydrogenase associated disorders, such as allograft rejection
04/04/2002US20020040020 Substituted pyrazoles
04/04/2002US20020040019 Substituted pyrazoles
04/04/2002US20020040002 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor
04/04/2002US20020039599 Calibration; administering antiseptic compound
04/04/2002US20020039577 Methods for regulating a lymphocyte-mediated immune response by blocking costimulatory signals and blocking LFA-1 mediated adhesion in lymphocytes
04/04/2002US20020039560 Drug delivery
04/04/2002DE10045591A1 Ortsspezifische, antikörpervermittelte Aktivierung proapoptotischer Zytokine - AMAIZe (Antibody-Mediated Apoptosis Inducing Zytokine) Site-specific, antibody-mediated activation of proapoptotic cytokines - Amaize (Antibody Mediated Apoptosis Inducing cytokines)
04/04/2002DE10044792A1 Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung Substituted Phenylcyclohexancarbonsäureamide and their use
04/04/2002CA2426666A1 Ion-strength independent sustained release pharmaceutical formulation
04/04/2002CA2423919A1 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai
04/04/2002CA2423903A1 O-substituted 6-methyltramadol derivatives
04/04/2002CA2423889A1 Methods and compositions for screening modulators of lipid kinases
04/04/2002CA2423805A1 Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin g
04/04/2002CA2423704A1 G-protein coupled receptors
04/04/2002CA2423694A1 Transferases
04/04/2002CA2423668A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
04/04/2002CA2423424A1 Secreted proteins
04/04/2002CA2423305A1 Compounds useful in the treatment of inflammatory diseases
04/04/2002CA2423251A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
04/04/2002CA2423141A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
04/04/2002CA2421851A1 Tgf-.beta. inhibitors and methods
04/04/2002CA2421209A1 Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases
04/04/2002CA2420577A1 Peptide-based compounds
04/04/2002CA2420475A1 Ige receptor antagonists
04/03/2002EP1193268A1 Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases
04/03/2002EP1193265A2 A process for the preparation of 4-[2-(aryl or heterocyclo)-1H-imidazol-1-yl]benzenesulfonamides
04/03/2002EP1193261A1 New thiadiazoles and their use as phosphodiesterase-7 inhibitors
04/03/2002EP1193257A2 Compounds for ceramide-mediated signal transduction
04/03/2002EP1193256A1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins
04/03/2002EP1193255A1 Heterocyclic compounds and medicinal use thereof
04/03/2002EP1192939A2 Methods for reduction of inflammation and erythema
04/03/2002EP1192271A1 Antisense modulation of interleukin-5 signal transduction
04/03/2002EP1192261A1 22025, a novel human cyclic nucleotide phosphodiesterase
04/03/2002EP1192258A2 Human poly(adp-ribose) polymerase 2 materials and methods
04/03/2002EP1192257A2 Human regulators of intracellular phosphorylation
04/03/2002EP1192250A2 Human rna metabolism proteins (rmep)
04/03/2002EP1192247A1 Sphingosine kinase enzyme
04/03/2002EP1192180A1 Product from starfish
04/03/2002EP1192171A1 48 human secreted proteins
04/03/2002EP1192170A1 Propargyl phenyl ether a2a receptor agonists
04/03/2002EP1192150A1 New pharmaceutically active compounds
04/03/2002EP1192147A1 Mycolactone and related compounds, compositions and methods of use
04/03/2002EP1192137A1 COMPOUNDS FOR THE MODULATION OF PPAR$g(g) ACTIVITY
04/03/2002EP1192133A1 N-cyclopentyl modulators of chemokine receptor activity
04/03/2002EP1192125A2 Mono- and disubstituted 3-propyl gamma-aminobutyric acids
04/03/2002EP1191941A1 A method for the prophylaxis and/or treatment of medical disorders
04/03/2002EP1191940A1 Tumor necrosis factor receptor 5
04/03/2002EP1191939A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
04/03/2002EP1191931A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
04/03/2002EP1161240A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
04/03/2002EP1009393B1 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
04/03/2002EP1007512B1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors
04/03/2002EP0873331B1 Benzofuran carboxamides and sulphonamides
04/03/2002EP0775199B1 Superoxide dismutase-4
04/03/2002EP0716600B1 Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
04/03/2002EP0676962B9 Enhanced pharmaceutical compositions for skin penetration for piroxicam
04/03/2002CN1343213A 2,3-0-isopropylidene derivatives of monosaccharides as cell adhesive inhibitors
04/03/2002CN1343212A Derivatives of monosaccharides as well adhesion inhibitors
04/03/2002CN1343208A Pyridopyranoazepine derivatives, preparation and therapeutic use
04/03/2002CN1343206A Cyclocompound
04/03/2002CN1343197A Biphenyl derivatives as antagonists of neurokinine-1 receptor
04/03/2002CN1343174A 计量阀 Metering valve
04/03/2002CN1343122A Remedies for joint diseases
04/03/2002CN1342490A Process for preparing staltic-antagic medicine to treat trauma
04/03/2002CN1342489A Liquid omphalotherapeutic medicine for treating abdominalgia
04/03/2002CN1342486A Chinese medicine preparation for broad-spectrum inflammation relieving, disinfecting, erosion prevention and muscle growing
04/03/2002CN1342478A Medical wine for treating rheumatism
04/03/2002CN1342472A Exterior-applied Chinese medicine for treating rheumatic and rheumatoid diseases
04/03/2002CN1342471A Antalgic Bingchan ointment and its preparing process
04/03/2002CN1342468A Capsule for treating rheumatic and rheumatoid arthritis and its preparing process
04/03/2002CN1342462A Composite medicine for treating rheumatoid arthritis
04/02/2002US6365768 Interleukin-1 and tumor necrosis factors-α modulators, syntheses of said modulators and methods of using modulators